Left Atrial Appendage Closure: Clinical Trials

3 trials for Left Atrial Appendage Closure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Active not recruiting 1, Recruiting 1, Unknown 1

Follow Left Atrial Appendage Closure: new trials by email Literature Review of Left Atrial Appendage Closure trials Research Report on Left Atrial Appendage Closure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Single Antiplatelet Therapy or No Therapy (Control), Non-Antithrombotic Therapy - Nonvalvular Atrial Fibrillation, Aspirin
Phase 4RecruitingOCEAN-SHD Study Group5002025-05-292025-08-15
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel -75 mg/day, Low dose aspirin -80 to 125 mg/day- - Left Atrial Appendage Closure, Thrombosis
Phase 4Active not recruitingCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec5102018-09-012026-03-27
A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure
Edoxaban, WATCHMAN LAA Closure, Aspirin and Clopidogrel - Non-Valvular Atrial Fibrillation, Left Atrial Appendage Closure
Phase 4UnknownScripps Health752017-03-232017-07-11

Narrower conditions

Hemorrhage (1)  ·  Stroke (1)  ·  Thrombosis (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Embolism and Thrombosis (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

edoxaban (2)  ·  Aspirin (1)  ·  Clopidogrel (1)  ·  Dabigatran (1)  ·  Rivaroxaban (1)  ·  Warfarin (1)  ·  apixaban (1)

Sponsors

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (1)  ·  OCEAN-SHD Study Group (1)  ·  Scripps Health (1)

Countries

Canada (1)  ·  Japan (1)  ·  United States (1)

Top investigators

Matthew J Price, MD (1)

Results publications

PMID 20665856, PMID 20723861, PMID 24682348, PMID 25060026, PMID 25604089, PMID 25777666, PMID 26993976, PMID 27765196, PMID 27931603, PMID 28065447, PMID 28145040, PMID 28231907, PMID 28495432, PMID 29146668, PMID 29183961, PMID 29622159, PMID 41139402, PMID 42003301